Status:
COMPLETED
Adrenomedullin in Context With Pulmonary Embolism
Lead Sponsor:
University of Pecs
Conditions:
Pulmonary Embolism
Eligibility:
All Genders
18+ years
Brief Summary
The pulmonary embolism (PE) causes a blockade of the pulmonary arteries typical due to a thrombus which is formed in the lower region of the body or pretty rare to other materials (tumor, air, fat). T...
Eligibility Criteria
Inclusion
- Patients with intermediate high and high risk of an acute pulmonary embolism with clinical symptoms.
- On image based procedures confirmed pulmonary embolism (TTE, contrast CT-angiography).
- Written agreement to the examination.
Exclusion
- Age under 18.
- Missing written agreement or cancelled agreement on any time.
Key Trial Info
Start Date :
August 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 8 2023
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04875130
Start Date
August 19 2020
End Date
May 8 2023
Last Update
May 11 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
KRAGES - Hospital of Oberwart
Oberwart, Burgenland, Austria, 7400
2
University Hospital of Pécs
Pécs, Baranya, Hungary, 7624